Influence of hepatitis B virus genotypes on the response to antiviral therapiesAKUTA, Norio; KUMADA, Hiromitsu.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 2, pp 139-142, issn 0305-7453, 4 p.Article

Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infectionTSUBOTA, Akihito; HIROSE, Yuichi; IZUMI, Namiki et al.British journal of clinical pharmacology. 2003, Vol 55, Num 4, pp 360-367, issn 0306-5251, 8 p.Article

Correlation Between Serum Hepatitis B Virus Core-Related Antigen and Intrahepatic Covalently Closed Circular DNA in Chronic Hepatitis B PatientsSUZUKI, Fumitaka; MIYAKOSHI, Hideo; KOBAYASHI, Mariko et al.Journal of medical virology. 2009, Vol 81, Num 1, pp 27-33, issn 0146-6615, 7 p.Article

Adjuvant interferon for hepatocellular carcinoma. Authors' replyOKADA, Shuichi; SATO, Toshiya; YAMAMOTO, Seiichiro et al.Hepatology (Baltimore, Md.). 2001, Vol 33, Num 2, pp 481-482, issn 0270-9139Article

A nucleotide sequence variation detection system for the core region of hepatitis C virus-1bOKAMOTO, Katsura; AKUTA, Norio; KUMADA, Hiromitsu et al.Journal of virological methods. 2007, Vol 141, Num 1, pp 1-6, issn 0166-0934, 6 p.Article

Classification of hepatitis B virus genotypes by the PCR-invader method with genotype-specific probesTADOKORO, Kenichi; KOBAYASHI, Mariko; YAMAGUCHI, Toshikazu et al.Journal of virological methods. 2006, Vol 138, Num 1-2, pp 30-39, issn 0166-0934, 10 p.Article

Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adwTSUBOTA, Akihito; ARASE, Yasushi; FENGRONG REN et al.Journal of medical virology. 2001, Vol 65, Num 2, pp 257-265, issn 0146-6615Article

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in JapanKUMADA, Hiromitsu; TOYOTA, Joji; OKANOUE, Takeshi et al.Journal of hepatology. 2012, Vol 56, Num 1, pp 78-84, issn 0168-8278, 7 p.Article

Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assayTADOKORO, Kenichi; SUZUKI, Fumitaka; KOBAYASHI, Mariko et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 67-73, issn 0166-0934, 7 p.Article

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-β in patients with genotype 1b hepatitis C infection: A multicenter randomized studyIZUMI, Namiki; KUMADA, Hiromitsu; HASHIMOTO, Naoaki et al.Digestive diseases and sciences. 2001, Vol 46, Num 3, pp 516-523, issn 0163-2116Conference Paper

Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TTKAWAKAMI, Yoshiiku; SUZUKI, Fumitaka; KARINO, Yoshiyasu et al.Antiviral therapy (London). 2014, Vol 19, Num 3, pp 277-285, issn 1359-6535, 9 p.Article

Psychiatric symptoms related to interferon therapy for chronic hepatitis C : Clinical features and prognosisHOSODA, Shinji; TAKIMURA, Hiroshi; SHIBAYAMA, Masatoshi et al.Psychiatry and clinical neurosciences (Carlton. Print). 2000, Vol 54, Num 5, pp 565-572, issn 1323-1316Article

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patientsONO, Atsushi; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of hepatology. 2012, Vol 57, Num 3, pp 508-514, issn 0168-8278, 7 p.Article

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis CCHAYAMA, Kazuaki; NELSON HAYES, C; KOBAYASHI, Mariko et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 84-93, issn 0022-1899, 10 p.Article

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersMIKI, Daiki; OCHI, Hidenori; TSUNODA, Tatsuhiko et al.Nature genetics. 2011, Vol 43, Num 8, pp 797-800, issn 1061-4036, 4 p.Article

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevirSUZUKI, Fumitaka; SUZUKI, Yoshiyuki; SAITO, Satoshi et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 76-78, issn 1386-6532, 3 p.Article

Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in japanese patients infected with hepatitis C virus genotype 1bAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1686-1695, issn 0146-6615, 10 p.Article

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis CARASE, Yasuji; IKEDA, Kenji; KOBAYASHI, Mariko et al.Journal of medical virology. 2007, Vol 79, Num 8, pp 1095-1102, issn 0146-6615, 8 p.Article

Long-term outcome of HBV carriers with negative hbe antigen and normal aminotransferase : Infectious diseaseIKEDA, Kenji; ARASE, Yasuji; KUMADA, Hiromitsu et al.The American journal of medicine. 2006, Vol 119, Num 11, pp 977-985, issn 0002-9343, 9 p.Article

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral loadTSUBOTA, Akihito; ARASE, Yasuji; KUMADA, Hiromitsu et al.Journal of medical virology. 2005, Vol 75, Num 1, pp 27-34, issn 0146-6615, 8 p.Article

Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus : Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survivalAKUTA, Norio; SUZUKI, Fumitaka; KOBAYASHI, Mariko et al.Scandinavian journal of gastroenterology. 2005, Vol 40, Num 6, pp 688-696, issn 0036-5521, 9 p.Article

Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndromeSUZUKI, Yoshiyuki; ARASE, Yasuji; KUMADA, Hiromitsu et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 6, pp 699-706, issn 0815-9319, 8 p.Article

Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV-HCV dual infectionAKUTA, Norio; SUZUKI, Fumitaka; IKEDA, Kenji et al.Digestive diseases and sciences. 2004, Vol 49, Num 2, pp 281-288, issn 0163-2116, 8 p.Article

Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patientsARASE, Yasuji; TSUBOTA, Akihito; KUMADA, Hiromitsu et al.Hepatology research. 2002, Vol 23, Num 2, pp 98-104, issn 1386-6346Article

Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinomaKOBAYASHI, Masahiro; IKEDA, Kenji; SOMEYA, Takashi et al.Oncology. 2002, Vol 63, Num 2, pp 139-144, issn 0030-2414Article